Balance Sheet

Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Beginning Cash Balance Beginning Cash Balance Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued Short-Term Debt repayments

Daily Values

Growth Metrics

Milestone Scientific (MLSS) Asset Writedowns and Impairment (2018 - 2025)

Milestone Scientific (MLSS) has disclosed Asset Writedowns and Impairment for 8 consecutive years, with $3114.0 as the latest value for Q4 2025.

Quarterly Asset Writedowns and Impairment changed N/A to $3114.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3114.0 through Dec 2025, down 99.02% year-over-year, with the annual reading at $11639.0 for FY2025, N/A changed from the prior year.
Asset Writedowns and Impairment hit $3114.0 in Q4 2025 for Milestone Scientific, down from $8789.0 in the prior quarter.
In the past five years, Asset Writedowns and Impairment ranged from a high of $8789.0 in Q4 2023 to a low of $3114.0 in Q4 2025.